In vitro activity of paris polyphylla smith against enterovirus 71 and coxsackievirus B3 and its immune modulation

American Journal of Chinese Medicine

Volumn 39, Issue 6, 2011, Pages 1219-1234

  Wang, Yuan Chuen ^a   Yi, Tsu Yi ^a   Lin, Kuei Hsiang ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Coxsackievirus B3; Cytokine; Enterovirus 71; Immune Modulation; Paris polyphylla Smith

Indexed keywords

ALCOHOL; ALPHA INTERFERON; ANTIVIRUS AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; PARIS POLYPHYLLA SMITH EXTRACT; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOKINE PRODUCTION; EMBRYO; ENTEROVIRUS 71; FEMALE; HUMAN; HUMAN CELL; IC 50; IMMUNOMODULATION; IN VITRO STUDY; INFECTION PREVENTION; NONHUMAN; PARIS POLYPHYLLA; PARIS POLYPHYLLA SMITH; VIRUS INACTIVATION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; COXSACKIEVIRUS INFECTIONS; CYTOKINES; ENTEROVIRUS A, HUMAN; ENTEROVIRUS B, HUMAN; HUMANS; IMMUNOLOGIC FACTORS; LILIACEAE; PLANT EXTRACTS;

EID: 81155138949     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11009512     Document Type: Article

References (43)

1. Bates, H.R. Jr. Coxsackievirus B3 calcific pancarditis and hydrops fetalis. Am. J. Obstet. Gynecol. 106: 629-630, 1970.
2. Bieker, J.M. Chemical Inactivation of Viruses, Ph.D. Thesis. Kansas State University, 2006.
3. Chen, C.S., Y.C. Yao, S.C. Lin, Y.P. Lee, Y.F. Wang, J.R. Wang, C.C. Liu, HY. Lei and C.K. Yu. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 81: 8996-9003, 2007.
4. Chiang, L.C., L.K. Ng, P.W. Cheng, W. Chiang and C.C. Lin. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin. Experim. Pharm. Physiol. 32: 811-816, 2005.
5. Chiu, NY. and K.H. Chang. The illustrated medicinal plants of Taiwan, Vol. 1. SMC Publishing Inc., Taipei, 1998.
6. Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immmunol. 27: 519-550, 2009.
7. Garozzo, A., C.C.C. Cutri, A. Castro, G. Tempera, F. Guerrera, M.C. Sarva and E. Geremia. Anti- rhinovirus activity of 3-methylthio-5-aryl-4- isothiazolecarbonitrile derivatives. Antiviral Res. 45: 199-210, 2000.
8. Genovese, D., C. Conti, P. Tomao, N. Desideri, ML. Stein, S. Catone and L. Fiore. Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Res. 27: 123-136, 1995.
9. Guo, J.P., J. Pang, X.W. Wang, Z.Q. Shen, M. Jin and J.W. Li. In vitro screening of traditionally used medicinal plants in China against enteroviruses. World J. Gastroenterol. 12: 4078-4081, 2006.
10. Guo, L., J. Su, B.W. Deng, ZY. Yu, L.P. Kang, Z.H. Zhao, Y.J. Shan, L.P. Chen, B.P. Ma and Y.W. Cong. Active pharmaceutical ingredients and mechanisms underlying phasic myometrial contractions stimulated with the saponin extract from Paris polyphylla Sm. var. yunnanensis used for abnormal uterine bleeding. Hum. Reprod. 23: 964-971, 2008.
11. Heim, A., S. Zeuke, S. Weiss, W. Ruschewski and I.M. Grumbach. Transient induction of cytokine production in human myocardial fibroblasts by Coxsackievirus B3. Circ. Res. 14: 753-759,2009.
12. Henke, A., S. Huber, A. Stelzner and J.L. Whitton. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69: 6720-6728, 1995.
13. Henke, A., H. Launhardt, K. Klement, A. Stelzner, R. Zell and T. Munder. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and proapoptotic protein siva. J. Virol. 74: 4284-4290, 2000.
14. Hofmann, P., M. Schmidtke, A. Stelzner and D. Gemsa. Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection. J. Med. Virol. 64: 487-498, 2001.
15. Huang, K.Y., X. Zhang, P.H. Chung, K.C. Tsao, TY. Lin, L.H. Su and C.H. Chiu. Enterovirus in Taiwan, 2004-2006: epidemiological and virological features. Scand. J. Infect. Dis. 40: 571-574, 2008.
16. Huber, S.A., A.M. Feldman and D. Sartini. Coxsakievirus B3 induces T reegulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ. Res. 99: 1109-1116, 2006.
17. Komatsu, H., Y. Shimizu, Y. Takeuchi, H. Ishiko and H. Takada. Outbreak of severe neurologic involvement associated with enterovirus 71 infection. Pediatr. Neurol. 20: 17-23, 1999.
18. Konstantinidou, A., H. Anninos, N. Spanakis, X. Kotsiakis, G. Syridou, A. Tsakris and E. Patsouris. Transplanctal infection of coxsakievirus B3 pathological findings in the fetus. J. Med. Virol. 79: 754-757, 2007.
19. Kuo, T.M., C.P. Hu, Y.L. Chen, M.H. Hong, K.S. Jeng, C.C. Liang, ML. Chen and CM. Chang. HBS replication is significantly reduced by IL-6. J. Biomed. Sci. 16: 41-49, 2009.
20. Li, Y., K.T. Leung, F. Yao, L.S. Ooi and V.E. Ooi. Antiviral flavans from the leaves of Pithe- cellobium clypearia. J. Nat. Prod. 69: 833-835, 2006.
21. Li, Y., R. Jiang, L.S. Ooi, P.P. But and V.E. Ooi. Antiviral triterpenoids from the medicinal plant Schefflera heptaphylla. Phytother. Res. 21: 466-470, 2007.
22. Lin, T.Y., C. Chu and C.H. Chiu. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 186: 1161-1164, 2002a.
23. Lin, T.Y., L.Y. Chang, S.H. Hsia, Y.C. Huang, C.H. Chiu, C. Hsueh, S.R. Shih, C.C. Liu and M.H. Wu. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34: S52-S57, 2002b.
24. Lin, T.Y., S.H. Hsia, Y.C. Huang, C.T. Wu and L.Y. Chang. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 36: 269-274, 2003.
25. Lin, T.Y., Y.C. Liu, J.R. Jheng, H.P. Tsai, J.T. J.T. Jan, W.R. Wong and J.T. Horng. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am. J. Chin. Med. 37: 143-158, 2009.
26. Mason, J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc. Res. 60: 5-10, 2003.
27. Mcdonnell, G. and A.D. Russell. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 12: 147-149, 1999.
28. McMinn, P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26: 91-107, 2002.
29. Mizuki, I., T. Shimoyama, S. Fukuda, Q. Liu, S. Nakaji and A. Munakata. Association of gastric epithelial apoptosis with the ability of Helicobacter pylori to induce a neutrophil oxidative burst. J. Med. Microbiol. 49: 521-524, 2000.
30. Nolan, M.A., M.E. Craig, M.M. Lahra, W.D. Rawlinson, P.C. Prager, G.D. Williams, A.M. Bye and P.I. Andrews. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 60: 1651-1656, 2003.
31. Poffenberger, M.C., N. Straka, N.E.I. Warry, D. Fang, I. Shanina and M.S. Horwitz. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PloS ONE 4: e627, 2009.
32. Roy, D., P.K.Y. Wong, R.S. Engelbrecht and E.S.K. Chian. Mechanism of enteroviral inactivation by ozone. Appl. Environ. Microb. 41: 718-723, 1981.
33. Shia, K.S., W.T. Li, C.M. Chang, M.C. Hsu, J.H. Chern, M.K. Leong, S.N. Tseng, C.C. Lee, Y.C. Lee, S.J. Chen, K.C. Peng, H.Y. Tseng, Y.L. Chang, C.L. Tai and S.R. Shih. Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors. J. Med. Chem. 245: 1644-1655, 2002.
34. Shih, S.R., K.N. Tsai, Y.S. Li, C.C. Chueh and E.C. Chan. Inhibition of enterovirus 71-induced apoptosis by allophycocyanin isolated from a blue-green alga Spirulina platensis. J. Med. Virol. 70: 119-125, 2003.
35. Su, M., Y. Li, K.T. Leung, Y. Chen, T. Li, R. Chen and V.E. Ooi. Antiviral activity and constituent of Ardisia chinensis Benth against coxsackie B3 virus. Phytother. Res. 20: 634-639, 2006.
36. Szalay, G., M. Sauter, J. Hald, A. Weinzieri, R. Kandolf and K. Klingel. Substained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders. Am. J. Pathol. 169: 2085-2093, 2006.
37. Tu, P.V., N.T.T. Thao, D. Perera, T.K. Huu, N.T.K. Tien, T.C. Thuong, O.M. How, M.J. Cardosa and P.C. McMinn. Epidemiologic and virologic investigation of hand, foot, and mouth disease, Southern Vietnam, 2005. Emerg. Infect. Dis. 13: 1733-1741, 2007.
38. Wang, H., Y. Ding, J. Zhou, X. Sun and S. Wang. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine 16: 146-115, 2009.
39. Wang, S.M., H.Y. Lei, M.C. Huang, L.Y. Su, H.C. Lin, C.K. Yu, J.L. Wang and C.C. Liu. Modulation of cytokine production by enterovirus immunoglobulin in patients with enter-ovirus 71-associated brainstem encephalitis. J. Clin. Virol. 37: 47-52, 2006.
40. Wang, Y.X., V. Cunha, J. Vincelette, K. White, S. Velichko, Y. Xu, C. Gross, R.M. Fitch, M. Halks-Miller, B.R. Larsen, T. Yajima, K.U. Knowlton, R. Vergona, M.E. Sullivan and E. Croze. Antiviral and myocyte protective effects of murine interferon-ß and -oi2 in coxsackievirus B3- induced myocarditis and epicarditis in Balb/c mice. Am. J. Physiol. Heart Circ. Physiol. 293: H69-H76, 2007.
41. Wu, B.W., T.L. Pan, Y.L. Leu, Y.K. Chang, P.J. Tai, K.H. Lin and J.T. Horng. Antiviral effects of Salvia miltiorrhiza (Danshen) against enterovirus 71. Am. J. Chin. Med. 35: 153-168, 2007.
42. Yan, L.L., Y.J. Zhang, WY. Gao, S.L. Ma and Y. Wang. In vitro and in vivo anticancer activity of steroid saponins of Paris ployphylla var. yunnanensis. Exp. Oncol. 31: 27-32, 2009.
43. Zhang, X.F., Y. Cui, J.J. Huang, Y.Z. Zhang, Z. Nie, L.F. Wang, B.Z. Yan, Y.L. Tang and Y. Liu. Immuno-stimulating properties of diosgenyl saponins isolated from Paris polyphylla. Bioorg. Med. Chem. Lett. 17: 2408-2413, 2007.